Milnacipran: Clinical Trials

9 trials of Milnacipran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated, 2 unknown. 9 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Terminated 3, Unknown 2
Phase 32Completed 2

Follow Milnacipran: new trials by email Literature Review of Milnacipran trials Research Report on Milnacipran

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
Ketamine, Milnacipran, Placebo - Depression
Phase 2 / Phase 3CompletedUniversity Hospital, Lille422016-09-082025-12-16
Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica
Morphine, Milnacipran - Neuropathic Pain
Phase 2UnknownRambam Health Care Campus1502013-07-012019-04-02
Prospective Study of the Influence of the Diffuse Noxious Inhibitory Controls of the Pain on the Efficacy of Milnacipran in Fibromyalgia Therapy
Milnacipran, Placebo - Fibromylagia
Phase 2UnknownUniversity Hospital, Clermont-Ferrand482013-04-012014-07-08
Milnacipran (Savella) in Irritable Bowel Syndrome (IBS)
Milnacipran, Placebo - Irritable Bowel Syndrome
Phase 2TerminatedSpencer Dorn, MD, MPH22012-04-012017-04-13
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Milnacipran, Placebo - Primary Fibromyalgia
Phase 2TerminatedForest Laboratories1162011-04-302019-05-14
Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Milnacipran - Primary Fibromyalgia
Phase 2TerminatedForest Laboratories572011-04-012013-09-30
Effect of Milnacipran in Chronic Neuropathic Low Back Pain
Milnacipran, Placebo - Low Back Pain
Phase 2CompletedNorthwestern University402010-10-012014-01-17
The Effect of Milnacipran in Patients With Fibromyalgia
Milnacipran, Placebo - Fibromyalgia
Phase 2 / Phase 3CompletedBeth Israel Medical Center372010-03-012016-06-30
Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran
Milnacipran, Placebo - Fibromyalgia Syndrome
Phase 2CompletedPierre Fabre Medicament1532006-09-012013-07-11

Conditions studied

Fibromyalgia (5)  ·  Fatigue (2)  ·  Pain (2)  ·  Abdominal Pain (1)  ·  Depression (1)  ·  Irritable Bowel Syndrome (1)  ·  Low Back Pain (1)  ·  Neoplasms (1)  ·  Neuralgia (1)  ·  Sciatica (1)

Sponsors

Forest Laboratories (2)  ·  Beth Israel Medical Center (1)  ·  Northwestern University (1)  ·  Pierre Fabre Medicament (1)  ·  Rambam Health Care Campus (1)  ·  Spencer Dorn, MD, MPH (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University Hospital, Lille (1)

Countries

United States (5)  ·  France (2)  ·  Israel (1)  ·  Switzerland (1)

Top investigators

Patricia M D'Astoli, LPN (2)  ·  Benjamin H Natelson, MD (1)  ·  Jules Desmeules, MD (1)  ·  Spencer D Dorn, MD, MPH (1)  ·  Thomas J Schnitzer, MD, PhD (1)

Results publications

PMID 26112278, PMID 25873248, PMID 26335989

NIH funding

2014 (1)